quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:04·683d
SECFiling
Fusion Pharmaceuticals Inc. logo

SEC Form EFFECT filed by Fusion Pharmaceuticals Inc.

FUSN· Fusion Pharmaceuticals Inc.
Health Care
Original source

Companies

  • FUSN
    Fusion Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Dec 27UpdateRaymond James$15.00
  • Sep 29UpdateOppenheimer$13.00
  • Jun 23UpdateRaymond James$13.00
  • Dec 1UpdateB. Riley Securities$10.00
  • Nov 30UpdateSVB Leerink$6.00
  • Sep 16UpdateTruist$10.00

Related

  • SEC675d
    SEC Form 15-12G filed by Fusion Pharmaceuticals Inc.
  • SEC683d
    SEC Form EFFECT filed by Fusion Pharmaceuticals Inc.
  • SEC683d
    SEC Form EFFECT filed by Fusion Pharmaceuticals Inc.
  • SEC687d
    SEC Form 25-NSE filed by Fusion Pharmaceuticals Inc.
  • INSIDER688d
    SEC Form 4 filed by Bitetti Teresa Marie
  • INSIDER688d
    Gannon Steven returned 56,400 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER688d
    Valliant John returned 318,147 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER688d
    SEC Form 4 filed by Cagnoni Pablo J
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022